Wenbin Jiang Cytek Biosciences, Inc. (CTKB) insider trading activity

CTKB Quotes by TradingView

Wenbin Jiang is PRESIDENT AND CEO of Cytek Biosciences, Inc.. Currently has a direct ownership of 5.16 Million shares of CTKB, which is worth approximately $28.1 Million. The most recent transaction as insider was on Feb 21, 2023, when has been sold 2,633 shares (Common Stock) at a price of $10.97 per share, resulting in proceeds of $28,884. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.16M
3.18% 3M change
2.62% 12M change
Total Value Held $28.1 Million

Wenbin Jiang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2023
SELL
Payment of exercise price or tax liability
$28,884 $10.97 p/Share
2,633 Reduced 0.03%
7,724,439 Common Stock
Feb 21 2023
BUY
Exercise of conversion of derivative security
-
6,758 Added 0.09%
7,727,072 Common Stock
Feb 07 2023
SELL
Open market or private sale
$263,800 $13.19 p/Share
20,000 Reduced 0.26%
7,720,314 Common Stock
Jan 09 2023
SELL
Open market or private sale
$213,200 $10.66 p/Share
20,000 Reduced 0.26%
7,740,314 Common Stock
Dec 07 2022
SELL
Open market or private sale
$237,200 $11.86 p/Share
20,000 Reduced 0.26%
7,760,314 Common Stock
Nov 29 2022
SELL
Bona fide gift
-
10,000 Reduced 0.13%
7,780,314 Common Stock
Nov 18 2022
SELL
Payment of exercise price or tax liability
$33,394 $14.75 p/Share
2,264 Reduced 0.03%
7,790,314 Common Stock
Nov 18 2022
BUY
Exercise of conversion of derivative security
-
6,758 Added 0.09%
7,792,578 Common Stock
Nov 07 2022
SELL
Open market or private sale
$295,200 $14.76 p/Share
20,000 Reduced 0.26%
7,785,820 Common Stock
Oct 07 2022
SELL
Open market or private sale
$295,800 $14.79 p/Share
20,000 Reduced 0.26%
7,805,820 Common Stock
Sep 07 2022
SELL
Open market or private sale
$257,800 $12.89 p/Share
20,000 Reduced 0.25%
7,825,820 Common Stock
Aug 18 2022
SELL
Payment of exercise price or tax liability
$34,855 $14.06 p/Share
2,479 Reduced 0.03%
7,845,820 Common Stock
Aug 18 2022
BUY
Exercise of conversion of derivative security
-
6,758 Added 0.09%
7,848,299 Common Stock
Aug 08 2022
SELL
Open market or private sale
$301,800 $15.09 p/Share
20,000 Reduced 0.25%
7,841,541 Common Stock
Jul 07 2022
SELL
Open market or private sale
$223,800 $11.19 p/Share
20,000 Reduced 0.25%
7,861,541 Common Stock
Jun 07 2022
SELL
Open market or private sale
$215,000 $10.75 p/Share
20,000 Reduced 0.25%
7,881,541 Common Stock
May 18 2022
SELL
Payment of exercise price or tax liability
$33,871 $9.65 p/Share
3,510 Reduced 0.04%
7,901,541 Common Stock
May 18 2022
BUY
Exercise of conversion of derivative security
-
9,011 Added 0.11%
7,905,051 Common Stock
May 09 2022
SELL
Open market or private sale
$160,200 $8.01 p/Share
20,000 Reduced 0.25%
7,896,040 Common Stock
Apr 07 2022
SELL
Open market or private sale
$210,800 $10.54 p/Share
20,000 Reduced 0.25%
7,916,040 Common Stock
Mar 07 2022
SELL
Open market or private sale
$263,800 $13.19 p/Share
20,000 Reduced 0.25%
7,936,040 Common Stock
Mar 04 2022
BUY
Exercise of conversion of derivative security
$16,666 $0.25 p/Share
66,665 Added 0.83%
7,956,040 Common Stock
Feb 07 2022
SELL
Open market or private sale
$288,000 $14.4 p/Share
20,000 Reduced 0.25%
7,889,375 Common Stock
Dec 04 2021
SELL
Bona fide gift
-
5,000 Reduced 0.06%
7,842,710 Common Stock
WJ

Wenbin Jiang

PRESIDENT AND CEO
Fremont, CA

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTKB